[go: up one dir, main page]

NI201200136A - Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación - Google Patents

Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación

Info

Publication number
NI201200136A
NI201200136A NI201200136A NI201200136A NI201200136A NI 201200136 A NI201200136 A NI 201200136A NI 201200136 A NI201200136 A NI 201200136A NI 201200136 A NI201200136 A NI 201200136A NI 201200136 A NI201200136 A NI 201200136A
Authority
NI
Nicaragua
Prior art keywords
ramipril
preparation
solid pharmaceutical
amlodipine besylate
pharmaceutical formulations
Prior art date
Application number
NI201200136A
Other languages
English (en)
Inventor
Jaiswal Nilesh
Khullar Praveen
Kulkarni Amol
Prajapati Dilip
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42786564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201200136(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NI201200136A publication Critical patent/NI201200136A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D11/00—Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of plastics material
    • B65D11/20—Details of walls made of plastics material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención está dirigida a composiciones farmacéuticas estables sólidas de dosis fija que comprenden ramipril, besilato de amlodipino y excipientes farmacéuticamente aceptables, y a su preparación.
NI201200136A 2010-02-24 2012-08-20 Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación NI201200136A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN417DE2010 2010-02-24

Publications (1)

Publication Number Publication Date
NI201200136A true NI201200136A (es) 2012-10-29

Family

ID=42786564

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201200136A NI201200136A (es) 2010-02-24 2012-08-20 Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación

Country Status (29)

Country Link
US (1) US20130146496A1 (es)
EP (1) EP2538924B1 (es)
JP (1) JP5719385B2 (es)
KR (1) KR20120130761A (es)
CN (1) CN102781430B (es)
AR (1) AR080256A1 (es)
AU (1) AU2010346977A1 (es)
BR (1) BR112012021203A2 (es)
CA (1) CA2790817A1 (es)
CL (1) CL2012002341A1 (es)
CR (1) CR20120432A (es)
EA (1) EA201290817A1 (es)
EC (1) ECSP12012121A (es)
ES (1) ES2483154T3 (es)
GT (1) GT201200248A (es)
MA (1) MA34130B1 (es)
MX (1) MX2012009689A (es)
NI (1) NI201200136A (es)
PE (1) PE20130004A1 (es)
PH (1) PH12012501684A1 (es)
PL (1) PL2538924T3 (es)
SG (1) SG183449A1 (es)
SI (1) SI2538924T1 (es)
TN (1) TN2012000363A1 (es)
TW (1) TW201138767A (es)
UA (1) UA105285C2 (es)
UY (1) UY33243A (es)
WO (1) WO2011104588A2 (es)
ZA (1) ZA201205559B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2814465B1 (en) * 2012-02-17 2019-07-03 Egis Gyógyszergyár Zrt. Pharmaceutical formulation having improved stability
PL227900B1 (pl) * 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CN104546773B (zh) * 2015-01-30 2018-12-11 华润赛科药业有限责任公司 一种高稳定性苯磺酸氨氯地平片及其制备方法
WO2016207824A2 (en) * 2015-06-23 2016-12-29 Dr. Reddy's Laboratories Ltd A stable pharmaceutical composition comprising ramipril and/or amlodipine
EP3501502A1 (en) * 2017-12-20 2019-06-26 Midas Pharma GmbH Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
WO2025133928A2 (en) * 2023-12-19 2025-06-26 Angelini Pharma S.P.A. Pharmaceutical matrices for prolonged drug release

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633496A1 (de) 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
ATE235251T1 (de) 1995-03-16 2003-04-15 Pfizer Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz
EE05670B1 (et) 1999-08-30 2013-08-15 Aventis Pharma Deutschland Gmbh Ramipriil kardiovaskulaarsete haigusjuhtude „rahoidmiseks
WO2005079772A2 (en) 2004-02-18 2005-09-01 Sepracor Inc. Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
HUP0401170A2 (en) * 2004-06-10 2006-09-28 Richter Gedeon Vegyeszet Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
ZA200704767B (en) * 2004-11-05 2008-08-27 King Pharmaceuticals Res & Dev Stabilized individually coated ramipril particles, compositions and methods
AU2005336956A1 (en) * 2005-09-28 2007-04-12 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
CN101272791A (zh) * 2005-09-28 2008-09-24 特瓦制药工业有限公司 苯磺酸氨氯地平和盐酸贝那普利的稳定的组合
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
US20080096863A1 (en) * 2006-10-19 2008-04-24 Torrent Pharmaceuticals Limited Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor

Also Published As

Publication number Publication date
AU2010346977A1 (en) 2012-09-13
ES2483154T3 (es) 2014-08-05
MA34130B1 (fr) 2013-04-03
PE20130004A1 (es) 2013-02-01
EP2538924B1 (en) 2014-05-21
CN102781430A (zh) 2012-11-14
CL2012002341A1 (es) 2012-11-30
CN102781430B (zh) 2015-09-09
CR20120432A (es) 2012-11-29
ECSP12012121A (es) 2012-09-28
EP2538924A2 (en) 2013-01-02
TN2012000363A1 (en) 2014-01-30
TW201138767A (en) 2011-11-16
GT201200248A (es) 2014-05-14
BR112012021203A2 (pt) 2016-05-17
SG183449A1 (en) 2012-09-27
SI2538924T1 (sl) 2014-09-30
EA201290817A1 (ru) 2013-01-30
MX2012009689A (es) 2012-09-12
US20130146496A1 (en) 2013-06-13
JP2013520485A (ja) 2013-06-06
KR20120130761A (ko) 2012-12-03
WO2011104588A3 (en) 2012-04-19
AR080256A1 (es) 2012-03-21
PL2538924T3 (pl) 2014-10-31
PH12012501684A1 (en) 2012-11-05
WO2011104588A2 (en) 2011-09-01
CA2790817A1 (en) 2011-09-01
ZA201205559B (en) 2013-09-25
UY33243A (es) 2011-09-30
UA105285C2 (uk) 2014-04-25
JP5719385B2 (ja) 2015-05-20

Similar Documents

Publication Publication Date Title
NI201100227A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
CL2023002345A1 (es) Composiciones y métodos para fabricar microparticulas de proteína.
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
NI201200136A (es) Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
DOP2012000279A (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
PH12012502083A1 (en) Manufacturing of active-free granules and tablets comprising the same
TN2015000135A1 (en) Modified release formulations for oprozomib
EA201500513A1 (ru) Продукт сомикронизации, включающий ацетат улипристала
BR112014020184A8 (pt) Preparação farmacêutica que contém anlodipina e ra-mipril
TR201007926A1 (tr) Prasugrel tablet formülasyonları.
EP2409685A3 (en) Orally-disintegrating formulations of prasugrel
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
HK1178450A (en) Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation